Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
NeuroBo Pharmaceuticals, Inc. (GEMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob... |
| 08/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/08/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events ... |
| 08/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/29/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
| 06/13/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/02/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/14/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/09/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/18/2023 |
8-K
| Quarterly results |
| 12/22/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/08/2022 |
8-K
| Quarterly results |
| 11/04/2022 |
8-K
| Quarterly results |
| 10/24/2022 |
8-K
| Quarterly results |
| 09/29/2022 |
8-K
| Quarterly results |
| 09/15/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 09/14/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 09/12/2022 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 06/10/2022 |
8-K
| Quarterly results |
| 04/01/2022 |
8-K
| Quarterly results |
| 03/21/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/28/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/14/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/15/2021 |
8-K
| Quarterly results |
| 11/04/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/04/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"COMMON STOCK PURCHASE WARRANT NEUROBO PHARMACEUTICALS, INC. Warrant Shares: _______ Issue Date:______, 2021 Initial Exercise Date: ___, 2021 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ___________ 1 and on or prior to 5:00 p.m. on ______________ 2 but not thereafter, to subscribe for and purchase from NeuroBo Pharmaceuticals, Inc., a Delaware corporation , up to ______ shares of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise ...",
"337-7700 Fax: 337-7701",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of October 1, 2021, between NeuroBo Pharmaceuticals, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act as to the Shares and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D promulgated thereunder as to the Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN...",
"Rx Communications GroupMichael Miller +1-917-633-6086" |
|
| 08/18/2021 |
8-K
| Quarterly results |
| 08/16/2021 |
8-K
| Quarterly results |
| 07/12/2021 |
8-K
| Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits |
| 05/17/2021 |
8-K
| Quarterly results |
|
|
|